Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 127, 2021 - Issue 6
109
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Anti-embolic and anti-oxidative effects of a novel (E)-4-amino-N′-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl) ethylidene) benzohydrazide against isoproterenol and vitamin-K induced ischemic stroke

, , , , , , , , & show all
Pages 527-540 | Received 21 Jul 2019, Accepted 14 Aug 2019, Published online: 30 Aug 2019

References

  • Ábrahám, H., et al., 2002. Filament size influences temperature changes and brain damage following middle cerebral artery occlusion in rats. Experimental brain research, 142(9), 131–138.
  • Almutairi, A.R., et al., 2017. Effectiveness and safety of non–vitamin k antagonist oral anticoagulants for atrial fibrillation and venous thromboembolism: a systematic review and meta-analyses. Clinical therapeutics, 39(7), 1456–1478.
  • Amarenco, P., et al., 2013. The ASCOD phenotyping of ischemic stroke (Updated ASCO Phenotyping). Cerebrovascular diseases, 36(1), 1–5.
  • Aras, A.B., et al., 2015. Neuroprotective effects of daidzein on focal cerebral ischemia injury in rats. Neural regeneration research, 10(1), 146–152.
  • Becker, R., 2005. The importance of factor Xa regulatory pathways in vascular thromboresistance: focus on protein Z. Journal of thrombosis and thrombolysis, 19(2), 135–137.
  • Cherubini, A., et al., 2005. Potential markers of oxidative stress in stroke. Free radical biology and medicine, 39(7), 841–852.
  • Di Napoli, M., Papa, F., and Bocola, V., 2001. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke, 32(1), 133–138.
  • Durukan, A., and Tatlisumak, T., 2008. Animal models of ischemic stroke. Handbook of clinical neurology, 92, 43–66.
  • Fann, D.Y., et al., 2013. Pathogenesis of acute stroke and the role of inflammasomes. Ageing research reviews, 12(4), 941–966.
  • Fisher, M., and Schaebitz, W., 2000. An overview of acute stroke therapy. Past, present, and future. Archives of internal medicine, 160(21), 3196–3206.
  • Fraga, C.G., Leibovitz, B.E., and Tappel, A.L., 1988. Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: characterization and comparison with homogenates and microsomes. Freeradical biology and medicine, 4(3), 155–161.
  • Gage, B.F., et al., 2001. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA, 285(22), 2864–2870.
  • Green, A.R., 2008. Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly. British journal of pharmacology, 153(S1), S325–S338.
  • Gula, L.J., et al., 2018. Elevated Incidence of Atrial Fibrillation and Stroke in Patients With Atrial Flutter: A Population-Based Study. Canadian journal of cardiology, 34(6), 774–783.
  • Hatano, S., 1976. Experience from a multicentre stroke register: a preliminary report. Bulletin of world health organisation, 54(5), 541–553.
  • Hirota-Kawadobora, M., et al., 2003. Fibrinogens Kosai and Ogasa: beta15Gly–>Cys (GGT–>TGT) substitution associated with impairment of fibrinopeptide B release and lateral aggregation. Journal of thrombosis and haemostasis, 1(2), 275–283.
  • Horan, J.T., and Francis, C.W., 2001. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation. Seminars in thrombosis and hemostasis, 27(06), 657–666.
  • Hornung, M., et al., 2016. Cardioembolic stroke and postmyocardial infarction stroke. Cardiology clinics, 34(2), 207–214.
  • Hu, H.J., and Song, M., 2017. Disrupted ionic homeostasis in ischemic stroke and new therapeutic targets. Journal of stroke and cerebrovascular diseases, 26(12), 2706–2719.
  • Hurtado, O., et al., 2003. Inhibition of glutamate release by delaying ATP fall accounts for neuroprotective effects of antioxidants in experimental stroke. The FASEB journal, 17(14), 2082–2084.
  • Jabre, P., et al., 2011. Mortality associated with atrial fi brillation in patients with myocardial infarction: a systematic review and meta- analysis. Circulation, 123(15), 1587–1593.
  • James, P., et al., 2000. Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study. BMJ (Clinical research ed.), 320(7248), 1502–1504.
  • Jickling, G.C., et al., 2014. Hemorrhagic transformation after ischemic stroke in animals and humans. Journal of cerebral blood flow and metabolism, 34(2), 185–199.
  • Johnston, S.C., et al., 2003. Prevalence and knowledge of transient ischemic attacks among us adults. Neurology, 60(9), 1429–1434.
  • Kakkar, P., Das, B., and Viswanathan, P.N., 1984. A modified spectrophotometric assay of superoxide dismutase. Indian journal of biochemistry and biophysics, 21(2), 130–132.
  • Kattula, S., Byrnes, J.R., and Wolberg, A.S., 2017. Fibrinogen and fibrin in hemostasis and thrombosis. Arteriosclerosis thrombosis and vascular biology, 37, 13–21.
  • Kerr, G., et al., 2009. Elevated troponin after stroke: a systematic review. Cerebrovascular diseases, 28(3), 220–226.
  • Kim, S.H., et al., 2016. Neuroprotective effects of Danggui-Jakyak-San on rat stroke model through antioxidant/antiapoptotic pathway. Journal of ethnopharmacology, 188, 123–133.
  • Kral, M., et al., 2013. Troponin T in acute ischemic stroke. American journal of cardiology, 112, 117–121.
  • Kumar, A., and Dogra, S., 2008. Pathophysiology and therapeutic strategies in the management of stroke: an update. Drugs of today (Barcelona, Spain: 1998), 44(10), 757–766.
  • Larsson, S., Traylor, M., and Markus, H., 2018. Circulating vitamin K1 levels in relation to ischemic stroke and its subtypes: a Mendelian randomization study. Nutrients, 10(11), 1575.
  • Lipton, P., 1999. Ischemic cell death in brain neurons. Physiological reviews, 79(4), 1431–1568.
  • Loh, K.Y., Wang, Z., and Liao, P., 2018. Oncotic cell death in stroke. Reviews of physiology biochemistry and pharmacology, 176, 37–64.
  • Lowry, O.H., et al., 1951. Protein measurement with Folin’s phenol reagent. Journal of biological chemistry, 193, 265–275.
  • Mărgăritescu, O.A., et al., 2009. Histopathological changes in acute ischemic stroke. Romanian journal of morphology and embryology, 50(3), 327–339.
  • Mekaj, Y.H., et al., 2015. New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events. Therapeutics and clinical risk management, 11, 967–977.
  • Mhairi, M.I., 1992. New models of focal cerebral ischaemia. British journal of clinical pharmacology, 34(4), 302–308.
  • Mishra, L.D., 2002. Cerebral blood flow and anaesthesia. Indian journal of anaesthesia, 46, 87–95.
  • Mnafgui, K., et al., 2016. Anti-inflammatory, antithrombotic and cardiac remodeling preventive effects of Eugenol in Isoproterenol-induced myocardial infarction in Wistar rat. Cardiovascular toxicology, 16(4), 336–344.
  • Muir, K.W., et al., 2007. Inflammation and ischaemic stroke. Current opinion in neurology, 20(3), 334–342.
  • Nieswandt, B., Pleines, I., and Bender, M., 2011. Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke. Journal of thrombosis and haemostasis, 9, 92–104.
  • Ondrejičková, O., et al., 1999. Effect of stobadine on lipid peroxidation in brain and heart after ischemia and reperfusion of the brain. Life sciences, 65(18-19), 1959–1961.
  • Ovbiagele, B., and Nguyen-Huynh, M.N., 2011. Stroke epidemiology: advancing our understanding of disease mechanism and therapy. Neurotherapeutics, 8(3), 319–329.
  • Pignataro, G., et al., 2014. Does Na+/Ca2+ exchanger, NCX, represent a new druggable target in stroke intervention? Translational stroke research, 5(1), 145–155.
  • Pradeep, H., et al., 2012. Oxidative stress–assassin behind the ischemic stroke. Folia neuropathologica, 50, 219–230.
  • Radu, R.A., et al., 2017. Etiologic classification of ischemic stroke: where do we stand? Clinical neurology and neurosurgery, 159, 93–106.
  • Reynolds, A., et al., 2007. Oxidative stress and the pathogenesis of neurodegenerative disorders. International review of neurobiology, 82, 297–325.
  • Riveiro, M.E., et al., 2010. Coumarins: old compounds with novel promising therapeutic perspectives. Current medicinal chemistry, 17(13), 1325–1338.
  • Rodrigues, F.S., et al., 2017. Effects of standard ethanolic extract from Erythrina velutina in acute cerebral ischemia in mice. Biomedicine and pharmacotherapy, 96, 1230–1239.
  • Ronden, J.E., et al., 1997. Modulation of arterial thrombosis tendency in rats by vitamin K and its side chains. Atherosclerosis, 132(1), 61–67.
  • Rotruck, J.T., et al., 1973. Selenium: biochemical role as a component of glutathione peroxidase. Science, 179(4073), 588–590.
  • Trailokya, A., et al., 2016. Acenocoumarol: a review of anticoagulant efficacy and safety. Journal of the association of physicians of India, 64(2), 88–93.
  • Turaj, W., et al., 2006. Increased plasma fibrinogen predicts one-year mortality in patients with acute ischemic stroke. Journal of the neurological sciences, 246(1–2), 13–19.
  • Ufer, M., 2005. Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol. Clinical pharmacokinetics, 44(12), 1227–1246.
  • Vennila, L., and Pugalendi, K.V., 2010. Protective effect of sesamol against myocardial infarction caused by isoproterenol in Wistar rats. Redox report, 15(1), 36–42.
  • Venugopala, K.N., Rashmi, V., and Odhav, B., 2013. Review on natural coumarin lead compounds for their pharmacological activity. Biomed research international, 2013, 963248.
  • Warden, B.A., Willman, A.M., and Williams, C.D., 2012. Antithrombotics for secondary prevention of noncardioembolic ischaemic stroke. Nature reviews neurology, 8(4), 223–235.
  • Weisel, J.W., and Litvinov, R.I., 2017. Fibrin formation, structure and properties. In: D.A.D. Parry, J.M., Squire eds. Fibrous proteins: structures and mechanisms. Cham, Switzerland: Springer, 405–432.
  • Willing, A.E., 2009. Experimental models: help or hindrance. Stroke, 40(3, Supplement 1), S152–S154.
  • Wong, J.A., and Healey, J.S., 2018. Incident atrial fibrillation and stroke in patients with atrial flutter. Canadian journal of cardiology, 34(6), 696–697.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.